Research programme: antibacterials - PanTherix

Drug Profile

Research programme: antibacterials - PanTherix

Alternative Names: PTX 007011; PTX 008134; PTX 008218; PTX 008313; PTX 008330; PTX 031553; PTX 040334; PTX 042695; PTX 110130

Latest Information Update: 08 Feb 2007

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator PanTherix
  • Class
  • Mechanism of Action Enzyme inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Bacterial infections

Most Recent Events

  • 21 Nov 2002 Preclinical trials in Bacterial infections in United Kingdom (unspecified route)
  • 21 Nov 2002 A preclinical study has been added to the Bacterial Infections pharmacodynamics section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top